Brief: Monte Rosa Therapeutics Announces Pricing Of $100 Mln Underwritten Public Offering
16/05/2024 12:15
May 16 (Reuters) - Monte Rosa Therapeutics Inc GLUE.O :
* MONTE ROSA THERAPEUTICS ANNOUNCES PRICING OF $100 MILLION
UNDERWRITTEN PUBLIC OFFERING
* MONTE ROSA THERAPEUTICS - PRICING OF AN UNDERWRITTEN
PUBLIC
OFFERING OF 10.6 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC
OFFERING PRICE OF $4.70 PER SHARE
Source text for Eikon: ID:nGNXbx21d1
Further company coverage: GLUE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monte Rosa Therapeutics
See all newsBrief: Monte Rosa Therapeutics Announces Positive Results For Mrt-8102 In Gforce-1 Phase 1 Study Showing Normalization Of Key Pathogenic Drivers Of Ascvd In Subjects With Elevated Cvd Risk
Brief: Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Monte Rosa Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Monte Rosa Therapeutics Q2 revenue drops, net loss widens on higher R&D
Brief: Monte Rosa Therapeutics Q2 Collaboration Revenue USD 8.968 Million